Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

DRIVE: A new European network for influenza vaccine effectiveness studies - Topi Turunen

49 views

Published on

Presentation by Topi Turunen at The Innovative Medicines Initiative (IMI): Celebrating 10 years of medical innovations
27.06.2018

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

DRIVE: A new European network for influenza vaccine effectiveness studies - Topi Turunen

  1. 1. Topi Turunen 22 & 23 October 2018 IMI Scientific Symposium Brussels, Belgium A new European network for influenza vaccine effectiveness studies
  2. 2. Vaccines are the cornerstone of preventing influenza but their effectiveness varies. Annual vaccine effectiveness studies are needed.
  3. 3. Multiple types of influenza vaccines on the market (and more on the way) (trivalent, quadrivalent, live attenuated, high-dose, adjuvanted, cell-based ...)
  4. 4. Since 2017, the European Medicines Agency requires brand-specific influenza vaccine effectiveness results from manufacturers. EMA encourages industry to liaise with public health authorities who have experience in influenza effectiveness studies and who have implemented a functioning infrastructure to conduct multicentre studies
  5. 5. A sustainable study network for brand-specific influenza vaccine effectiveness studies in the EU A governance model for transparent, scientifically robust public-private partnerships is a public-private partnership launched by the Innovative Medicines Initiative in 2017 to establish:
  6. 6. www.imi.europa.eu @IMI_JU Thank you

×